We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Investigating Drugs of Abuse with Applied Biosystems LC/MS/MS Systems
News

Investigating Drugs of Abuse with Applied Biosystems LC/MS/MS Systems

Investigating Drugs of Abuse with Applied Biosystems LC/MS/MS Systems
News

Investigating Drugs of Abuse with Applied Biosystems LC/MS/MS Systems

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Investigating Drugs of Abuse with Applied Biosystems LC/MS/MS Systems"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Biochemists at the Leeds Teaching Hospital are delighted with their API 3000™ LC/MS/MS systems from Applied Biosystems, which they are using to develop methods for looking at drugs of abuse, their metabolites and chemicals used in the treatment of drug addiction.

Mr Keith Allen, Consultant Biochemist, explained, "The two API 3000 systems can analyse oral fluid and urine, looking for up to 30 compounds simultaneously using multiple reaction monitoring chromatography."

"The beauty of using LC/MS/MS in this way is that you can look for the metabolites too; drug identification and confirmation shouldn't just be based on a parent compound."

"We have already published a method using these systems to distinguish illicit heroin from pharmaceutical grade heroin in oral fluid samples and we are now working on a method that determines the effectiveness of naltrexone implants, used for treating heroin addiction, by measuring naltrexone and its metabolite naltrexol in oral fluid and serum."

Mr Allen concluded, "We are very happy with these systems. Compared to immunoassays, LC/MS/MS is certainly the way forward."

Advertisement